These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14512527)

  • 1. Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons.
    Guo JT; Zhu Q; Seeger C
    J Virol; 2003 Oct; 77(20):10769-79. PubMed ID: 14512527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alpha interferon on the hepatitis C virus replicon.
    Guo JT; Bichko VV; Seeger C
    J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon.
    Hazari S; Taylor L; Haque S; Garry RF; Florman S; Luftig R; Regenstein F; Dash S
    Virol J; 2007 Sep; 4():89. PubMed ID: 17877826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
    Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
    Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system.
    Escuret V; Martin A; Durantel D; Parent R; Hantz O; Trépo C; Menguy T; Bottius E; Dardy J; Maral J; Escary JL; Zoulim F
    Antimicrob Agents Chemother; 2006 Dec; 50(12):3984-91. PubMed ID: 17030563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway.
    Frese M; Pietschmann T; Moradpour D; Haller O; Bartenschlager R
    J Gen Virol; 2001 Apr; 82(Pt 4):723-733. PubMed ID: 11257176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
    Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
    PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.
    Taylor DR; Puig M; Darnell ME; Mihalik K; Feinstone SM
    J Virol; 2005 May; 79(10):6291-8. PubMed ID: 15858013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
    Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
    Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance.
    Zhu H; Nelson DR; Crawford JM; Liu C
    J Interferon Cytokine Res; 2005 Sep; 25(9):528-39. PubMed ID: 16181053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype.
    Namba K; Naka K; Dansako H; Nozaki A; Ikeda M; Shiratori Y; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 2004 Oct; 323(1):299-309. PubMed ID: 15351737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the interferon alpha response against hepatitis C virus replicons.
    Guo JT; Sohn JA; Zhu Q; Seeger C
    Virology; 2004 Jul; 325(1):71-81. PubMed ID: 15231387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
    Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
    J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.
    Yamauchi S; Takeuchi K; Chihara K; Honjoh C; Kato Y; Yoshiki H; Hotta H; Sada K
    Sci Rep; 2016 Dec; 6():38336. PubMed ID: 27929099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional protein kinase C inhibition prevents alpha interferon-mediated hepatitis C virus replicon clearance by impairing STAT activation.
    Fimia GM; Evangelisti C; Alonzi T; Romani M; Fratini F; Paonessa G; Ippolito G; Tripodi M; Piacentini M
    J Virol; 2004 Dec; 78(23):12809-16. PubMed ID: 15542633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities.
    Chang KS; Cai Z; Zhang C; Sen GC; Williams BR; Luo G
    J Virol; 2006 Aug; 80(15):7364-74. PubMed ID: 16840317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.